Cyoprecipitate is rich in factor –
**Core Concept**
Cyoprecipitate is a blood product that contains various coagulation factors. It is derived from plasma that has been treated with a cryoprecipitation process, resulting in a concentrated source of certain clotting factors.
**Why the Correct Answer is Right**
Cyoprecipitate is rich in factor VIII, a crucial coagulation factor essential for the intrinsic pathway of blood coagulation. Factor VIII serves as a cofactor for factor IXa in the activation of factor X to factor Xa. The cryoprecipitation process selectively concentrates factor VIII, along with other factors such as fibrinogen, factor XIII, and von Willebrand factor. This makes cyoprecipitate a valuable component in the treatment of hemophilia A and other bleeding disorders.
**Why Each Wrong Option is Incorrect**
**Option A:** Factor II - Incorrect because cyoprecipitate does not contain a significant amount of factor II (prothrombin).
**Option B:** Factor VII - Incorrect because factor VII is not concentrated in cyoprecipitate.
**Option C:** Factor XIII - While factor XIII is present in cyoprecipitate, it is not the primary factor associated with this blood product.
**Clinical Pearl / High-Yield Fact**
Cyoprecipitate is often used in the treatment of hemophilia A, and its administration can be life-saving in patients with severe bleeding episodes. However, it is essential to note that fresh frozen plasma (FFP) can also be used as a source of factor VIII, but cyoprecipitate is generally preferred due to its higher concentration of this essential coagulation factor.
**Correct Answer: D. Factor VIII. Factor VIII.**